Phase 3 trial results bring hope for patients with IgA nephropathy. Haraldsson B. Lancet 2023 Aug 14:S0140-6736(23)01633-1. doi: 10.1016/S0140-6736(23)01633.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Haraldsson B. Phase 3 trial results bring hope for patients with IgA nephropathy. Lancet 2023 Aug 14:S0140-6736(23)01633-1. doi: 10.1016/S0140-6736(23)01633.
PMID: 37591290